Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andrew McDowell is active.

Publication


Featured researches published by Andrew McDowell.


The Lancet | 2001

Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis

Anthony De Soyza; Andrew McDowell; L. Archer; John H. Dark; Stuart Elborn; Eshwar Mahenthiralingam; Kate Gould; Paul Corris

Burkholderia cepacia is a group of organisms that comprises seven genotypically distinct species (B cepacia genomovars I-VII), which are collectively known as the B cepacia complex. Preoperative infection with B cepacia is associated with a poor prognosis in lung transplant recipients with cystic fibrosis. Many centres do not, therefore, offer transplants to these individuals. Our aim was to ascertain whether or not post-transplant mortality is affected by pretransplant genomovar status. We studied archived isolates with PCR-based methods, and recorded excessive mortality in patients infected with B cepacia genomovar III, but not in those infected with other genomovars.


Journal of Clinical Microbiology | 2001

PCR-Based Detection and Identification of Burkholderia cepacia Complex Pathogens in Sputum from Cystic Fibrosis Patients

Andrew McDowell; Eshwar Mahenthiralingam; John E. Moore; K. E. A. Dunbar; A. K. Webb; M. E. Dodd; S. L. Martin; B. C. Millar; Christopher J. Scott; M. Crowe; J.S. Elborn

ABSTRACT PCR amplification of the recA gene followed by restriction fragment length polymorphism (RFLP) analysis was investigated for the rapid detection and identification ofBurkholderiacepacia complex genomovars directly from sputum. Successful amplification of the B.cepacia complex recA gene from cystic fibrosis (CF) patient sputum samples containing B.cepacia genomovar I, Burkholderiamultivorans, B. cepaciagenomovar III, Burkholderiastabilis, andBurkholderiavietnamiensis was demonstrated. In addition, the genomovar identifications determined directly from sputum were the same as those obtained after selective culturing. Sensitivity experiments revealed thatrecA-based PCR could reliably detect B.cepacia complex organisms to concentrations of 106 CFU g of sputum−1. To fully assess the diagnostic value of the method, sputum samples from 100 CF patients were screened for B. cepacia complex infection by selective culturing and recA-based PCR. Selective culturing identified 19 samples with presumptiveB. cepacia complex infection, which was corroborated by phenotypic analyses. Of the culture-positive sputum samples, 17 were also detected directly by recA-based PCR, while 2 samples were negative. The isolates cultured from bothrecA-negative sputum samples were subsequently identified as Burkholderiagladioli. RFLP analysis of the recA amplicons revealed 2 patients (12%) infected with B. multivorans, 11 patients (65%) infected with B. cepaciagenomovar III-A, and 4 patients (23%) infected with B.cepacia genomovar III-B. These results demonstrate the potential of recA-based PCR-RFLP analysis for the rapid detection and identification of B.cepacia complex genomovars directly from sputum. Where the sensitivity of the assay proves a limitation, sputum samples can be analyzed by selective culturing followed by recA-based analysis of the isolate.


European Respiratory Journal | 2003

Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa

A.M. Jones; Lorraine Martin; R. Bright-Thomas; M.E. Dodd; Andrew McDowell; Kelly Moffitt; J.S. Elborn; A.K. Webb

Chronic Pseudomonas aeruginosa infection in cystic fibrosis (CF) leads to a damaging host inflammatory response. There are an increasing number of reports of P. aeruginosa cross-infection at CF centres. The clinical significance of acquisition of a transmissible strain for patients who already harbour P. aeruginosa is unclear. In this study, levels of inflammatory markers in clinically stable adult CF patients who harbour transmissible and sporadic strains of P. aeruginosa have been compared. Patients with CF and chronic P. aeruginosa infection were grouped into those who harbour a transmissible P. aeruginosa and those who harbour their own sporadic strains. Total white cell and differential counts, sputum neutrophil elastase (NE), interleukin (IL)‐8, tumour necrosis factor (TNF)‐α, plasma IL‐6 and NE/α1‐antitrypsin complexes, serum C‐reactive protein, and urine TNF receptor 1 were all measured in clinically stable patients 4–6 weeks following completion of intravenous antibiotic therapy. The two groups (both n=20) were well matched for per cent predicted forced expiratory volume in one second, per cent predicted forced vital capacity and body mass index. There were no significant differences in levels of white cell counts or inflammatory markers between the two groups. At times of clinical stability, cystic fibrosis patients infected with transmissible Pseudomonas aeruginosa do not have a heightened inflammatory response above that of those harbouring sporadic strains.


Bioorganic & Medicinal Chemistry Letters | 2000

Inhibition of escherichia coli glucosamine synthetase by novel electrophilic analogues of glutamine—comparison with 6-diazo-5-oxo-norleucine

Brian Walker; Martin F. Brown; John F. Lynas; S. Lorraine Martin; Andrew McDowell; Bernard Badet; Alan J. Hill

A series of electrophilic glutamine analogues based on 6-diazo-5-oxo-norleucine has been prepared, using novel synthetic routes, and evaluated as inhibitors of Escherichia coli glucosamine synthetase. The gamma-dimethylsulphonium salt analogue of glutamine was found to be one of the most potent inactivators of this enzyme yet reported, with an apparent second order rate constant (k2/Ki) of 3.5 x 10(5) M(-1) min(-1).


Annals of Clinical Microbiology and Antimicrobials | 2004

Organisms isolated from adults with cystic fibrosis

Terence E McManus; Andrew McDowell; John E. Moore; Stuart Elborn

BackgroundPatients with cystic fibrosis [CF] have frequent pulmonary exacerbations associated with the isolation of bacterial organisms from sputum samples. It is not clear however, if there are differences in the types of additional organisms isolated from patients who are infected with Burkholderia cepacia complex [BCC] or Pseudomonas aerugionsa [PA] in comparison to those who are not infected with either of these organisms [NI].MethodsAdult patients attending the regional CF unit were followed over a two year period and patients were assigned to three groups depending on whether they were known to be chronically infected with BCC, PA or NI. We compared the numbers and types of organisms which were isolated in each of these groups.ResultsInformation was available on a total of 79 patients; BCC 23, PA 30 and NI 26. Total numbers of organisms isolated, expressed as median and IQR for each group, [P = 0.045] and numbers of co-infecting organisms [P = 0.003] were significantly higher in the BCC group compared to PA, and in the PA group [P < 0.001, p = 0.007 respectively] compared to NI patients. The pattern of co-infecting organisms was similar in all three groups.ConclusionsTotal numbers of organisms isolated and numbers of co-infecting organisms were significantly higher in the BCC group compared to PA, and in the PA group compared to NI patients. Types of co-infecting organisms are similar in all groups of patients.


Journal of Cystic Fibrosis | 2004

Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults

Julia Courtney; K. Dunbar; Andrew McDowell; John E. Moore; T.J. Warke; M. Stevenson; J.S. Elborn


Journal of Medical Microbiology | 2004

Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation

Andrew McDowell; Eshwar Mahenthiralingam; Kerstin E. A. Dunbar; John E. Moore; M. Crowe; J. Stuart Elborn


Archive | 2012

Order XII Propionibacteriales ord. nov.

Sheila Patrick; Andrew McDowell


Archive | 2017

Pre-spinal surgery skin antisepsis with povidone iodine-alcohol followed by chlorhexidine gluconate-alcohol versus povidone iodine-alcohol applied twice for prevention of surgical wound contamination by bacteria: a randomised, controlled trial.

Sheila Patrick; Andrew McDowell; Andrew W. Lee; Alessandra Frau; Una Martin; Evie Gardiner; Gregory McLorinan; Niall Eames


Archive | 2013

Editorial Propionibacterium acnes in Human Health and Disease

Andrew McDowell; Sheila Patrick; Yoshinobu Eishi; Peter A. Lambert; Anne Eady

Collaboration


Dive into the Andrew McDowell's collaboration.

Top Co-Authors

Avatar

Lorraine Martin

Queen's University Belfast

View shared research outputs
Top Co-Authors

Avatar

J.S. Elborn

Queen's University Belfast

View shared research outputs
Top Co-Authors

Avatar

Sheila Patrick

Queen's University Belfast

View shared research outputs
Top Co-Authors

Avatar

John E. Moore

Public health laboratory

View shared research outputs
Top Co-Authors

Avatar

John F. Lynas

Queen's University Belfast

View shared research outputs
Top Co-Authors

Avatar

Brian A. Walker

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Kelly Moffitt

Queen's University Belfast

View shared research outputs
Top Co-Authors

Avatar

A.K. Webb

University of Manchester

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge